Cogent Biosciences, Inc. (COGT) Shareholders’ equity 2018–2021
Cogent Biosciences, Inc. (COGT) shareholders’ equity at each fiscal year-end, per SEC filings.
$234.7MFY2021 · since FY2018: -$48.8M → $234.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $234.7M | +638.8% |
| FY2020 | $31.8M | -47.3% |
| FY2019 | $60.2M | +223.3% |
| FY2018 | -$48.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice